Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?

Introduction: End-stage renal disease (ESRD) related to HIV is becoming a leading cause of renal replacement therapy requirement is some areas of the world. Our study aims to describe the incidence and renal outcomes of HIV-associated nephropathy (HIVAN), and immune-mediated kidney disease related...

Full description

Saved in:
Bibliographic Details
Main Authors: Oscar Muñoz-Velandia, Ángel García-Peña, Javier Garzón-Herazo, Kateir Contreras-Villamizar, Martha Rodríguez-Sánchez, Elias Garcia-Consuegra, Esteban Toro-Trujillo
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2020-09-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/12030
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850186762209460224
author Oscar Muñoz-Velandia
Ángel García-Peña
Javier Garzón-Herazo
Kateir Contreras-Villamizar
Martha Rodríguez-Sánchez
Elias Garcia-Consuegra
Esteban Toro-Trujillo
author_facet Oscar Muñoz-Velandia
Ángel García-Peña
Javier Garzón-Herazo
Kateir Contreras-Villamizar
Martha Rodríguez-Sánchez
Elias Garcia-Consuegra
Esteban Toro-Trujillo
author_sort Oscar Muñoz-Velandia
collection DOAJ
description Introduction: End-stage renal disease (ESRD) related to HIV is becoming a leading cause of renal replacement therapy requirement is some areas of the world. Our study aims to describe the incidence and renal outcomes of HIV-associated nephropathy (HIVAN), and immune-mediated kidney disease related to HIV (HIVICK) in Colombia. Methodology: A retrospective cohort study was performed, including all HIVAN or HIVICK incident cases assessed by the infectious diseases division in a high complexity institution in Colombia, between 2004 and 2018. A longitudinal data model under the Generalized Estimating Equations (GEE) method was used to determine changes on the glomerular filtration rate (GFR) over time. Results: Within a cohort composed by 1509 HIV-infected patients, we identified 22 with HIV-associated glomerular disease. Cumulative incidence was 1.45%. At diagnosis, GFR was above 30 mL/min in 90.8% of patients, and 77.2% displayed sub-nephrotic proteinuria. Factors associated with GFR at diagnosis were: level of CD4 (Coefficient 0.113, CI 95 %: 0.046, 0.179, p < 0.01), and the inverse of the CD4/CD8 ratio. The GEE model did not demonstrate significant changes in the GFR over a 3-year period. Findings were similar when comparing GFR at diagnosis with GFR at 12 (-3.9 mL/min/1.73m2, CI 95% -7.3, 0.4, p = 0.98), 24 (-2.47 mL/min/1.73m2, CI 95% -7.0, 2.1, p=0.85), and 36 months (0.39 mL/min/1.73m2, CI 95% -4.4, 5.2, p = 0.43) of follow-up. Conclusions: Patients with glomerular disease associated with HIV have stable GFR over a 3-year period, and low rates of progression towards dialysis requirement. Differences with previous reports could be related with early diagnosis and treatment with highly active antiretroviral therapy.
format Article
id doaj-art-6a8ebb0da1b14779b35c5ee07928af0f
institution OA Journals
issn 1972-2680
language English
publishDate 2020-09-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-6a8ebb0da1b14779b35c5ee07928af0f2025-08-20T02:16:17ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802020-09-01140910.3855/jidc.12030Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?Oscar Muñoz-Velandia0Ángel García-Peña1Javier Garzón-Herazo2Kateir Contreras-Villamizar3Martha Rodríguez-Sánchez4Elias Garcia-Consuegra5Esteban Toro-Trujillo6Department of Internal Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, ColombiaDepartment of Internal Medicine, Cardiology Unit, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, ColombiaDepartment of Internal Medicine, Infectology Unit, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, ColombiaDepartment of Internal Medicine, Nephrology Unit, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, ColombiaDepartment of Internal Medicine, Nephrology Unit, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, ColombiaDepartment of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, ColombiaDepartment of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia Introduction: End-stage renal disease (ESRD) related to HIV is becoming a leading cause of renal replacement therapy requirement is some areas of the world. Our study aims to describe the incidence and renal outcomes of HIV-associated nephropathy (HIVAN), and immune-mediated kidney disease related to HIV (HIVICK) in Colombia. Methodology: A retrospective cohort study was performed, including all HIVAN or HIVICK incident cases assessed by the infectious diseases division in a high complexity institution in Colombia, between 2004 and 2018. A longitudinal data model under the Generalized Estimating Equations (GEE) method was used to determine changes on the glomerular filtration rate (GFR) over time. Results: Within a cohort composed by 1509 HIV-infected patients, we identified 22 with HIV-associated glomerular disease. Cumulative incidence was 1.45%. At diagnosis, GFR was above 30 mL/min in 90.8% of patients, and 77.2% displayed sub-nephrotic proteinuria. Factors associated with GFR at diagnosis were: level of CD4 (Coefficient 0.113, CI 95 %: 0.046, 0.179, p < 0.01), and the inverse of the CD4/CD8 ratio. The GEE model did not demonstrate significant changes in the GFR over a 3-year period. Findings were similar when comparing GFR at diagnosis with GFR at 12 (-3.9 mL/min/1.73m2, CI 95% -7.3, 0.4, p = 0.98), 24 (-2.47 mL/min/1.73m2, CI 95% -7.0, 2.1, p=0.85), and 36 months (0.39 mL/min/1.73m2, CI 95% -4.4, 5.2, p = 0.43) of follow-up. Conclusions: Patients with glomerular disease associated with HIV have stable GFR over a 3-year period, and low rates of progression towards dialysis requirement. Differences with previous reports could be related with early diagnosis and treatment with highly active antiretroviral therapy. https://jidc.org/index.php/journal/article/view/12030HIVglomerular diseasesHIV-associated nephropathyhighly active antiretroviral therapy
spellingShingle Oscar Muñoz-Velandia
Ángel García-Peña
Javier Garzón-Herazo
Kateir Contreras-Villamizar
Martha Rodríguez-Sánchez
Elias Garcia-Consuegra
Esteban Toro-Trujillo
Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
Journal of Infection in Developing Countries
HIV
glomerular diseases
HIV-associated nephropathy
highly active antiretroviral therapy
title Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
title_full Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
title_fullStr Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
title_full_unstemmed Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
title_short Glomerular diseases related to HIV in Colombian population: Better outcomes with highly active antiretroviral therapy?
title_sort glomerular diseases related to hiv in colombian population better outcomes with highly active antiretroviral therapy
topic HIV
glomerular diseases
HIV-associated nephropathy
highly active antiretroviral therapy
url https://jidc.org/index.php/journal/article/view/12030
work_keys_str_mv AT oscarmunozvelandia glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT angelgarciapena glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT javiergarzonherazo glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT kateircontrerasvillamizar glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT martharodriguezsanchez glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT eliasgarciaconsuegra glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy
AT estebantorotrujillo glomerulardiseasesrelatedtohivincolombianpopulationbetteroutcomeswithhighlyactiveantiretroviraltherapy